Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Procaps Group S.A.

Procaps Group S.A. (PROC) Stock Overview

Explore Procaps Group S.A.’s financial performance, market position, analyst ratings, and future outlook.

PROC●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.01
$0.00(0.00%)
U.S. Market is Open · 13:55

Procaps Group S.A. (PROC)

Meyka AI Score

Z

Key Financials

Market Cap102.1M
P/E Ratio2.40
EPS (TTM)$0.66
ROE-2.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PROC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Procaps Group S.A. (NASDAQ: PROC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Procaps Group S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PROC on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Procaps Group S.A.'s NASDAQ-traded stock include a P/E ratio of 2.40 and a market capitalization of 102.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PROC on the NASDAQ.

Price Performance (NASDAQ: PROC)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-9.82%
3-Year Change
-77.65%
5-Year Change
-89.98%
All-Time (Max) Change
-89.74%

Contact Information

https://sofgenpharma.com
356 7995 6138
9 Rue de Bitbourg, Luxembourg City, NaN, 1273

Company Facts

55,000 Employees
IPO DateDec 9, 2019
CountryLU

Frequently Asked Questions